Insider’s View: Deciphering Alnylam Pharmaceuticals Inc (ALNY)’s Financial Health Through Ratios

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) closed at $270.46 in the last session, up 3.96% from day before closing price of $260.17. In other words, the price has increased by $3.96 from its previous closing price. On the day, 0.83 million shares were traded. ALNY stock price reached its highest trading level at $271.76 during the session, while it also had its lowest trading level at $261.86.

Ratios:

We take a closer look at ALNY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 108.89. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.01.

On December 08, 2023, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $171.Wells Fargo initiated its Equal Weight rating on December 08, 2023, with a $171 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 06 ’24 when Ausiello Dennis A bought 20,250 shares for $266.66 per share.

Ausiello Dennis A sold 20,250 shares of ALNY for $5,305,586 on Aug 06 ’24. The Director now owns 136 shares after completing the transaction at $262.00 per share. On Aug 01 ’24, another insider, Greenstreet Yvonne, who serves as the Officer of the company, bought 15,148 shares for $270.00 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALNY now has a Market Capitalization of 34721923072 and an Enterprise Value of 34805383168. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.81. Its current Enterprise Value per Revenue stands at 14.846 whereas that against EBITDA is 220.326.

Stock Price History:

Over the past 52 weeks, ALNY has reached a high of $274.93, while it has fallen to a 52-week low of $141.98. The 50-Day Moving Average of the stock is 26.54%, while the 200-Day Moving Average is calculated to be 53.70%.

Shares Statistics:

According to the various share statistics, ALNY traded on average about 1.11M shares per day over the past 3-months and 1122150 shares per day over the past 10 days. A total of 128.38M shares are outstanding, with a floating share count of 127.65M. Insiders hold about 0.57% of the company’s shares, while institutions hold 89.24% stake in the company. Shares short for ALNY as of 1721001600 were 4493570 with a Short Ratio of 4.06, compared to 1718323200 on 2128914. Therefore, it implies a Short% of Shares Outstanding of 4493570 and a Short% of Float of 4.04.

Most Popular